PCI Biotech Holding ASA (DE:4QG) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
PCI Biotech has announced the awarding of 885,000 share options to key employees, with a three-year vesting term and a strike price of NOK 1.81. Among the recipients, CEO/CFO Ronny Skuggedal received 400,000 options, increasing his total unexercised options to 1,020,000. The long-term incentive plan aims to encourage executives to maintain a significant level of company share ownership.
For further insights into DE:4QG stock, check out TipRanks’ Stock Analysis page.
